EMERGENT BIOSOLUTIONS
Emergent BioSolutions is a global life sciences company that is driven by a mission to protect and enhance life. It develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
EMERGENT BIOSOLUTIONS
Industry:
Biotechnology Health Care Life Science Manufacturing Pharmaceutical
Founded:
1998-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.emergentbiosolutions.com
Total Employee:
1001+
Status:
Active
Contact:
240-631-3200
Email Addresses:
[email protected]
Total Funding:
36.5 M USD
Technology used in webpage:
Viewport Meta Mobile Non Scaleable Content JQuery CDN GoDaddy SSL Java EE GlobalSign FLoC Twitter Timeline Amazon Elastic Load Balancing Sticky Session Amazon ALB
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
BIOSAFE
Biosafe manufactures patented polymers that improve performance in personal care, consumer, and healthcare products.
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Cytek Biosciences
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Ethypharm
Ethypharm designs, formulates, develops, manufactures, and markets pharmaceutical products for the treatment of pains and addictions.
International Isotopes
International Isotopes develops and deploys technological solutions for radiology-related treatments.
JA Saúde Animal
J.A Saúde Animal specializes in research, development, manufacturing, and commercialization of products for animal health.
Lighting Science Group
Lighting Science Group designs, develops, manufactures, and markets general illumination products that use light-emitting diodes.
Merit Medical Systems
Merit Medical Systems, a healthcare firm, manufactures medical devices used in interventional cardiology and radiology procedures.
Microvi Biotechnologies
Microvi Biotechnologies develops, manufactures, and commercializes biocatalytic technologies in the water, energy, and chemical industries.
Olive Lifesciences
Olive Lifesciences is a manufacturer and supplier of botanical extracts and phytochemicals.
OptiSource International
OptiSource International manufactures and distributes optical goods, equipment, and supplies to optometrists, opticians, and labs.
Repligen
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Sanofi Pasteur
Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally.
SHANGHAI JIAODA ONLLY CO LTD
Shanghai Jiaoda Onlly Co., Ltd. develops, manufactures, and markets biological products, healthcare food, ginseng products
SmithKline Beecham Pharmaceuticals (SB)
SmithKline Beecham plc develops products and services related to pharmaceuticals, biologics, vaccines, and consumer healthcare.
Stirling Ultracold
Stirling Ultracold develops and manufactures environmentally friendly, ultra-low temperature freezers.
The Stevanato Group
Stevanato Group S.p.A. manufactures packaging containers from glass tubing for the pharmaceutical industry worldwide.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-08-28 | Adapt Pharma | Adapt Pharma acquired by Emergent BioSolutions | N/A |
2018-08-09 | PaxVax | PaxVax acquired by Emergent BioSolutions | N/A |
2017-07-17 | Sanofi - smallpox vaccine | Sanofi - smallpox vaccine acquired by Emergent BioSolutions | 125 M USD |
2013-12-11 | Cangene | Cangene acquired by Emergent BioSolutions | N/A |
2010-08-12 | Trubion Pharmaceuticals | Trubion Pharmaceuticals acquired by Emergent BioSolutions | 135.5 M USD |
2005-06-27 | Microscience | Microscience acquired by Emergent BioSolutions | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Emergent BioSolutions
Key Employee Changes
Date | New article |
---|---|
2022-03-16 | Emergent BioSolutions appoints new executives to leadership team |
2020-04-09 | Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs |
Official Site Inspections
http://www.emergentbiosolutions.com Semrush global rank: 1.03 M Semrush visits lastest month: 33.11 K
- Host name: 45.60.106.21
- IP address: 45.60.106.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Emergent BioSolutions"
Organization Update in Lansing, Michigan - Emergent BioSolutions
Aug 26, 2024 View printer-friendly version. Organization Update in Lansing, Michigan. GAITHERSBURG, Md., August 26, 2024 – Emergent continues to transform operations across …See details»
About Us - Emergent BioSolutions
Our Mission At Emergent, we develop, manufacture, and deliver protections against public health threats through a pipeline of innovative vaccines and therapeutics worldwide. For 25 years, we’ve been at work defending people …See details»
Emergent BioSolutions - Wikipedia
Emergent BioSolutions was founded on September 5, 1998, by Fuad El-Hibri, under the name BioPort, which had formerly operated as a state-owned entity named Michigan Biological Products Institute and was privatized as Emergent BioSolutions in 2004. At the time, the Michigan Department of Public Health, though its Michigan Biologics Products Institute, owned an anthrax vaccine manufacturing facility in Lansing, Michigan. BioPort purchased the facility and the rights …See details»
Emergent BioSolutions - LinkedIn
Emergent BioSolutions | 42,937 followers on LinkedIn. Protecting against emerging global health threats. | At Emergent, we develop, manufacture, and deliver protections against public health threats.See details»
About Us - Emergent Bio
Fast Facts: Emergent's Bioservices Division ; Industries Served. Established mid-sized biotech & large pharma Government & non-government research organizationsSee details»
Emergent BioSolutions - Bioservices (CDMO)
About Emergent Bioservices. We are the Bioservices (CDMO) division of Emergent BioSolutions, a global company providing solutions that address public health threats. With 25 years of experience developing, manufacturing, and …See details»
Emergent BioSolutions - Crunchbase Company Profile & Funding
Emergent BioSolutions is a global life sciences company that is driven by a mission to protect and enhance life. It develops, manufactures, and delivers a portfolio of medical countermeasures …See details»
2022 Annual Report - Emergent BioSolutions Inc.
Incorporation or Organization) (I.R.S. Employer Identification No.) 400 Professional Drive, Suite 400 (Address of Principal Executive Offices) Gaithersburg, MD 20879 (City) (State) (Zip Code) …See details»
Emergent BioSolutions - LinkedIn
Emergent BioSolutions | 42,969 followers on LinkedIn. Protecting against emerging global health threats. | At Emergent, we develop, manufacture, and deliver protections against public health …See details»
Contact Us - Emergent BioSolutions
Corporate Office. 300 Professional Drive, Suite 400 Gaithersburg, MD 20879. Tel: 240-631-3200 Fax: 240-631-3203See details»
Emergent BioSolutions - Overview, News & Similar companies
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions …See details»
Emergent BioSolutions Corporate Update
Non-GAAP Financial Measures 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference 3 INTRODUCTION This presentation contains four financial measures Adjusted …See details»
Emergent Biosolutions Canada Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Emergent Biosolutions Canada Inc of Winnipeg, MB. Get the latest business insights from Dun & …See details»
Emergent BioSolutions Inc - Company Profile - GlobalData
Website emergentbiosolutions.com Telephone 1 240 6313200. No of Employees 2,416. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange EBS (NYSE) Revenue (2022) …See details»
Emergent Biosolutions - Craft
Oct 29, 2024 Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats. It offers smallpox vaccines, anthrax immune …See details»
This is Emergent Winnipeg – Emergent BioSolutions
Dec 12, 2022 Winnipeg is one of Emergent’s largest sites, with approximately 400 employees. It’s Emergent’s only site that operates through a product’s full lifecycle, from development to …See details»
Working at Emergent BioSolutions - Zippia
Find out what it's like to work at Emergent BioSolutions. See what kind of people work at Emergent BioSolutions, career paths working at Emergent BioSolutions, company culture, …See details»
0001193125-24-268963 | S-1/A | Emergent BioSolutions Inc.
The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Emergent BioSolutions Announces Growth Strategy and 2024 …
Evolve culture – Evolve the organization’s culture to support employee engagement and empowerment. 2024 Financial and Operational Goals ... Additional information about the …See details»
Careers – Emergent BioSolutions
May 15, 2023 Notice to Emergent BioSolutions Candidates. If you need a reasonable accommodation for any part of the employment process, please send an email to …See details»